We have previously demonstrated that the genetic deletion of MMP12 in a cardiometabolic mouse model ameliorates obesity-induced low-grade inflammation, white adipose tissue dysfunction, and atherosclerosis. The gene discussed is MMP12; the disease is obesity due to melanocortin 4 receptor deficiency.